BIO.B · Company research
Bio-Rad Laboratories, Inc. Class B (BIO.B): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
21records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A 2 p.m. Pacific call is scheduled to discuss Bio-Rad's third-quarter results Nov. 4. - Stock Titan | A 2 p.m. Pacific call is scheduled to discuss Bio-Rad's third-quarter results Nov. 4. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| Bio-Rad Laboratories, Inc. (BIO-B) Stock Price, News, Quote & History - Yahoo! Finance Canada | Bio-Rad Laboratories, Inc. (BIO-B) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 7, 2026 | neutral | 0 | 0.6 |
| Neogen (NEOG) Q1 Earnings and Revenues Beat Estimates | Neogen reported quarterly earnings of $0.08 per share, beating consensus estimates of $0.05 and marking a 60% earnings surprise. The company also exceeded revenue expectations with $222.8 million, up from $209.19 million year-over-year. Despite strong performance, Neogen's Medical-Products industry ranks in the bottom 35% of Zacks industries. The stock has gained 86.1% year-to-date and holds a Zacks Rank #2 (Buy) rating. | View source ↗ | Zacks Investment Research | Oct 6, 2026 | bullish | 0.333 | 1 |
| Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation | The global microfluidics market is projected to grow from $21.58 billion in 2025 to $48.04 billion by 2036, with a CAGR of 7.49%. Growth is driven by rising demand for rapid diagnostics, point-of-care testing, genomic analysis, and automated workflows. Microfluidic consumables dominate with 66.7% market share, while Asia-Pacific is expected to register the highest regional growth at 8.72% CAGR. | View source ↗ | GlobeNewswire Inc. | Oct 6, 2026 | bullish | 1 | 1 |
| Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation | The global microfluidics market is projected to grow from $21.58 billion in 2025 to $48.04 billion by 2036, with a CAGR of 7.49%. Growth is driven by rising demand for rapid diagnostics, point-of-care testing, genomic analysis, and automated workflows. Microfluidic consumables dominate with 66.7% market share, while Asia-Pacific is expected to register the highest regional growth at 8.72% CAGR. | View source ↗ | GlobeNewswire Inc. | Oct 6, 2026 | bullish | 1 | 1 |
| Europe Point of Care Diagnostics Market Size and Forecast, 2021 - 2031 | Market to Reach US$21.4 Billion by 2031 as Rapid Testing and Molecular Innovation Drive 13.4% CAGR | Europe's Point of Care (POC) Diagnostics Market is projected to grow from US$8.9 billion in 2024 to US$21.4 billion by 2031, with a 13.4% CAGR driven by rapid testing innovation, molecular diagnostics advancement, and increasing prevalence of infectious and chronic diseases. Germany leads the regional market, supported by strong healthcare infrastructure and public health initiatives. Key players include Siemens AG, Abbott Laboratories, Roche, bioMerieux, Bio-Rad, QIAGEN, Nova Biomedical, Polymer Technology Systems, and Danaher Corp. | View source ↗ | GlobeNewswire Inc. | Oct 5, 2026 | bullish | 1 | 1 |
| Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR | The global immunogenomics market is projected to grow from USD 6.32 billion in 2025 to USD 9.82 billion by 2033, expanding at a CAGR of 5.97%. Growth is driven by advancements in next-generation sequencing technologies, increasing demand for personalized medicine, and rising prevalence of immune-related disorders. Key applications include oncology, infectious disease research, vaccine development, and autoimmune disorder studies, with adoption across hospitals, diagnostic laboratories, pharmaceutical companies, and academic institutions. | View source ↗ | GlobeNewswire Inc. | Oct 5, 2026 | bullish | 1 | 1 |
| Magnetic Beads Market - Global Forecast and Growth Opportunities, 2026-2032 | Automation, Genomics, and Molecular Diagnostics Drive 7.91% CAGR Toward USD 6.18 Billion | The global magnetic beads market is projected to grow from USD 3.90 billion in 2026 to USD 6.18 billion by 2032, driven by automation, molecular diagnostics, genomics, and bioprocessing applications. Key growth drivers include adoption of automated magnetic separation platforms, advanced surface chemistries, AI-enabled workflow optimization, and expanding diagnostics capacity across regions. Strategic priorities for industry leaders include developing application-specific chemistries, strengthening supply-chain resilience, and leveraging AI analytics. | View source ↗ | GlobeNewswire Inc. | Oct 5, 2026 | bullish | 1 | 1 |
| Hong Kong Stock Market Alert | Xuanzhu Bio-B (02575) surges 20% in afternoon trading after the company previously announced preliminary discussions regarding a potential acquisition. - Moomoo | Hong Kong Stock Market Alert | Xuanzhu Bio-B (02575) surges 20% in afternoon trading after the company previously announced preliminary discussions regarding a potential acquisition. Moomoo | View source ↗ | Moomoo | Sep 29, 2026 | neutral | 0 | 0.6 |
| Starbucks Upgraded, Ralph Lauren Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace | Starbucks Upgraded, Ralph Lauren Downgraded: Updated Rankings on Top Blue-Chip Stocks InvestorPlace | View source ↗ | InvestorPlace | Aug 31, 2026 | neutral | 0 | 0.6 |
| Bio-Rad: Activist Involvement Highlights Value-Unlocking Potential (NYSE:BIO) - Seeking Alpha | Bio-Rad: Activist Involvement Highlights Value-Unlocking Potential (NYSE:BIO) Seeking Alpha | View source ↗ | Seeking Alpha | Jul 2, 2026 | neutral | 0 | 0.6 |
| Bio-Rad Reports First-Quarter 2026 Financial Results - Business Wire | Bio-Rad Reports First-Quarter 2026 Financial Results Business Wire | View source ↗ | Business Wire | Apr 30, 2026 | neutral | 0 | 0.6 |
| Bio-Rad Laboratories Still Hampered By Underwhelming Core Growth - Seeking Alpha | Bio-Rad Laboratories Still Hampered By Underwhelming Core Growth Seeking Alpha | View source ↗ | Seeking Alpha | Jan 22, 2026 | neutral | 0 | 0.6 |
| Bio-Rad Laboratories: Macroeconomic Uncertainty And A Limited Growth Potential Give Pause - Seeking Alpha | Bio-Rad Laboratories: Macroeconomic Uncertainty And A Limited Growth Potential Give Pause Seeking Alpha | View source ↗ | Seeking Alpha | Aug 7, 2025 | neutral | 0 | 0.6 |
| Bio-Rad Laboratories (BIO) Stock Price, News & Analysis - Stock Titan | Bio-Rad Laboratories (BIO) Stock Price, News & Analysis Stock Titan | View source ↗ | Stock Titan | Apr 24, 2025 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 2, 2024 | neutral | 0 | 0.6 |
| Bio-Rad Laboratories, Inc. (BIO.B) Company Information - Simply Wall Street | Bio-Rad Laboratories, Inc. (BIO.B) Company Information Simply Wall Street | View source ↗ | Simply Wall Street | Aug 25, 2022 | neutral | 0 | 0.6 |
| Bio-Rad Laboratories (BIO) Stock News & Updates - Stock Titan | Bio-Rad Laboratories (BIO) Stock News & Updates Stock Titan | View source ↗ | Stock Titan | Oct 20, 2020 | neutral | 0 | 0.6 |
| Top Bio-Rad Laboratories (BIO.B) Competitors 2026 - MarketBeat | Top Bio-Rad Laboratories (BIO.B) Competitors 2026 MarketBeat | View source ↗ | MarketBeat | Apr 28, 2020 | neutral | 0 | 0.6 |
| Bio-Rad Laboratories (BIO.B) Stock Chart and Price History 2026 - MarketBeat | Bio-Rad Laboratories (BIO.B) Stock Chart and Price History 2026 MarketBeat | View source ↗ | MarketBeat | Mar 15, 2020 | neutral | 0 | 0.6 |
| Bio-Rad Laboratories, Inc. (BIO-B) stock price, news, quote and history - Yahoo Finance Singapore | Bio-Rad Laboratories, Inc. (BIO-B) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | May 11, 2017 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.